RNA interference. Drugging RNAi.
RNAi Therapeutics Consulting, Rastatt, Germany. dirk.haussecker@gmail.com markay@stanford.edu.
Dirk
D
Haussecker
Pediatrics and Genetics, Stanford University, Stanford, CA, USA. dirk.haussecker@gmail.com markay@stanford.edu.
Mark A
MA
Kay
D028227:Amyloid Neuropathies, Familial / Q000235:genetics / Q000628:therapy; D002318:Cardiovascular Diseases / Q000628:therapy; D016503:Drug Delivery Systems; D055808:Drug Discovery; D018390:Gene Targeting / Q000379:methods*; D006509:Hepatitis B / Q000628:therapy*; D006801:Humans; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000628:therapy; D053758:Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D011228:Prealbumin / Q000235:genetics; D034622:RNA Interference; D012330:RNA, Double-Stranded / Q000235:genetics; D012333:RNA, Messenger / Q000037:antagonists & inhibitors; D034741:RNA, Small Interfering / Q000235:genetics*; D013698:Templates, Genetic
D011228:Prealbumin; D012330:RNA, Double-Stranded; D012333:RNA, Messenger; D034741:RNA, Small Interfering